Oliva, Stefania http://orcid.org/0000-0002-3084-180X
De Paoli, Lorenzo
Ruggeri, Marina
Caltagirone, Simona
Troia, Rossella
Oddolo, Daniela
D’Agostino, Mattia
Gilestro, Milena
Mina, Roberto
Saraci, Elona
Margiotta Casaluci, Gloria
Genuardi, Elisa
Bringhen, Sara
Boccadoro, Mario
Omedé, Paola
Article History
Received: 8 June 2020
Accepted: 16 December 2020
First Online: 3 January 2021
Compliance with ethical standards
:
: SO has received honoraria from Amgen, Celgene, and Janssen and has served on the advisory boards for Adaptive Biotechnologies, Janssen, Amgen, and Takeda. MD has received honoraria for lectures from Sanofi and GSK and has served on the advisory boards for GSK. RM has received honoraria from Sanofi, Celgene, Takeda, and Janssen; has served on the advisory boards for Sanofi, Takeda, and Janssen; and has received consultancy fees from Janssen. SB has received honoraria from Celgene, Amgen, Janssen, and Bristol-Myers Squibb; has served on the advisory boards for Celgene, Amgen, Janssen, and Karyopharm; and has received consultancy fees from Janssen and Takeda. MB has received honoraria from Sanofi, Celgene, Amgen, Janssen, Novartis, Bristol-Myers Squibb, and AbbVie; has served on the advisory boards for Janssen and GSK; and has received research funding from Sanofi, Celgene, Amgen, Janssen, Novartis, Bristol-Myers Squibb, and Mundipharma. PO has served on the advisory boards for Janssen. The other authors declare no competing financial interests.
: All procedures followed were in accordance with the ethical standards of the responsible committees on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Patients gave written informed consent before bone marrow aspiration and before starting therapy.